You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK — Barclays on Tuesday initiated coverage of Danaher, Ortho Clinical Diagnostics, and Thermo Fisher Scientific with Overweight ratings. The investment bank set a price target for Danaher at $260, Ortho at $25, and Thermo Fisher at $525.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.